These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15212844)

  • 1. Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages: implications for the pathogenesis of Alzheimer's disease.
    Xiong H; McCabe L; Costello J; Anderson E; Weber G; Ikezu T
    Neurobiol Aging; 2004 Aug; 25(7):905-11. PubMed ID: 15212844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of NR1a/NR2B receptors by monocyte-derived macrophage secretory products: implications for human immunodeficiency virus type one-associated dementia.
    Xiong H; McCabe L; Skifter D; Monaghan DT; Gendelman HE
    Neurosci Lett; 2003 May; 341(3):246-50. PubMed ID: 12697294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid β peptide oligomers directly activate NMDA receptors.
    Texidó L; Martín-Satué M; Alberdi E; Solsona C; Matute C
    Cell Calcium; 2011 Mar; 49(3):184-90. PubMed ID: 21349580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.
    Ikezu T; Luo X; Weber GA; Zhao J; McCabe L; Buescher JL; Ghorpade A; Zheng J; Xiong H
    J Neurochem; 2003 May; 85(4):925-34. PubMed ID: 12716424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes.
    Avenet P; Léonardon J; Besnard F; Graham D; Frost J; Depoortere H; Langer SZ; Scatton B
    Eur J Pharmacol; 1996 Jan; 296(2):209-13. PubMed ID: 8838458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
    Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
    Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits.
    Domingues A; Almeida S; da Cruz e Silva EF; Oliveira CR; Rego AC
    Neurochem Int; 2007 May; 50(6):872-80. PubMed ID: 17403555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling.
    Shimazawa M; Inokuchi Y; Okuno T; Nakajima Y; Sakaguchi G; Kato A; Oku H; Sugiyama T; Kudo T; Ikeda T; Takeda M; Hara H
    J Neurochem; 2008 Oct; 107(1):279-90. PubMed ID: 18691390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-secretase processing of APLP1 leads to the production of a p3-like peptide that does not aggregate and is not toxic to neurons.
    Minogue AM; Stubbs AK; Frigerio CS; Boland B; Fadeeva JV; Tang J; Selkoe DJ; Walsh DM
    Brain Res; 2009 Mar; 1262():89-99. PubMed ID: 19401174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons.
    Shelat PB; Chalimoniuk M; Wang JH; Strosznajder JB; Lee JC; Sun AY; Simonyi A; Sun GY
    J Neurochem; 2008 Jul; 106(1):45-55. PubMed ID: 18346200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice.
    Dewachter I; Filipkowski RK; Priller C; Ris L; Neyton J; Croes S; Terwel D; Gysemans M; Devijver H; Borghgraef P; Godaux E; Kaczmarek L; Herms J; Van Leuven F
    Neurobiol Aging; 2009 Feb; 30(2):241-56. PubMed ID: 17673336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of huperzine A on amyloid precursor protein processing and beta-amyloid generation in human embryonic kidney 293 APP Swedish mutant cells.
    Peng Y; Jiang L; Lee DY; Schachter SC; Ma Z; Lemere CA
    J Neurosci Res; 2006 Sep; 84(4):903-11. PubMed ID: 16862548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723).
    Reis K; Zharkovsky A; Bogdanovic N; Karelson E; Land T
    Neuroscience; 2007 Jan; 144(2):571-8. PubMed ID: 17101228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
    Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z
    Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation.
    Ye C; Walsh DM; Selkoe DJ; Hartley DM
    Neurosci Lett; 2004 Aug; 366(3):320-5. PubMed ID: 15288443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.
    Tamiz AP; Cai SX; Zhou ZL; Yuen PW; Schelkun RM; Whittemore ER; Weber E; Woodward RM; Keana JF
    J Med Chem; 1999 Aug; 42(17):3412-20. PubMed ID: 10464027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Secretase, APP and Abeta in Alzheimer's disease.
    Vassar R
    Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.